Transition from insulin to oral sulfonylurea therapy in children with diabetes due to activating mutations in KCNJ11

被引：0
|
作者：
Greeley, Siri Atma W.
Bordini, Brian D.
Edidin, Deborah V.
Littlejohn, Elizabeth E.
Philipson, Louis H.
机构：
来源：
DIABETES | 2007年 / 56卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：A699 / A699
页数：1
相关论文
共 50 条
  • [1] Outpatient transition of an infant with permanent neonatal diabetes due to a KCNJ11 activating mutation from subcutaneous insulin to oral glyburide
    Bremer, Andrew A.
    Ranadive, Sayali
    Lustig, Robert H.
    PEDIATRIC DIABETES, 2008, 9 (03) : 236 - 239
  • [2] Transition from insulin to sulfonylurea in a child with diabetes due to a mutation in KCNJ11 encoding Kir6.2-initial and long-term response to sulfonylurea therapy
    Wagner, Verena M.
    Kremke, Britta
    Hiort, Olaf
    Flanagan, Sarah E.
    Pearson, Ewan R.
    EUROPEAN JOURNAL OF PEDIATRICS, 2009, 168 (03) : 359 - 361
  • [3] Transition from insulin to sulfonylurea in a child with diabetes due to a mutation in KCNJ11 encoding Kir6.2—initial and long-term response to sulfonylurea therapy
    Verena M. Wagner
    Britta Kremke
    Olaf Hiort
    Sarah E. Flanagan
    Ewan R. Pearson
    European Journal of Pediatrics, 2009, 168 : 359 - 361
  • [4] Permanent neonatal diabetes due to activating mutations in ABCC8 and KCNJ11
    Emma L. Edghill
    Sarah E. Flanagan
    Sian Ellard
    Reviews in Endocrine and Metabolic Disorders, 2010, 11 : 193 - 198
  • [5] Permanent neonatal diabetes due to activating mutations in ABCC8 and KCNJ11
    Edghill, Emma L.
    Flanagan, Sarah E.
    Ellard, Sian
    REVIEWS IN ENDOCRINE & METABOLIC DISORDERS, 2010, 11 (03): : 193 - 198
  • [6] Permanent neonatal diabetes mellitus due to KCNJ11 mutation in a Portuguese family: transition from insulin to oral sulfonylureas
    Dupont, Juliette
    Pereira, Carla
    Medeira, Ana
    Duarte, Rui
    Ellard, Sian
    Sampaio, Lurdes
    JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM, 2012, 25 (3-4): : 367 - 370
  • [7] Relapsing diabetes can result from moderately activating mutations in KCNJ11
    Gloyn, AL
    Reimann, F
    Proks, P
    Pearson, ER
    Temple, IK
    Mackay, DJG
    Shield, JPH
    Freedenberg, D
    Noyes, K
    Ellard, S
    Ashcroft, FM
    Gribble, FM
    Hattersley, AT
    HUMAN MOLECULAR GENETICS, 2005, 14 (07) : 925 - 934
  • [8] Successful sulfonylurea treatment of an insulin-naive neonate with diabetes mellitus due to a KCNJ11 mutation
    Wambach, Jennifer A.
    Marshall, Bess A.
    Koster, Joseph C.
    White, Neil H.
    Nichols, Colin G.
    PEDIATRIC DIABETES, 2010, 11 (04) : 286 - 288
  • [9] KCNJ11 activating mutations in Italian patients with permanent neonatal diabetes
    Massa, O
    Iafusco, D
    D'Amato, E
    Gloyn, AL
    Hattersley, AT
    Pasquino, B
    Tonini, G
    Dammacco, F
    Zanette, G
    Meschi, F
    Porzio, O
    Bottazzo, G
    Crinó, A
    Lorini, R
    Cerutti, F
    Vanelli, M
    Barbetti, F
    HUMAN MUTATION, 2005, 25 (01) : 22 - 27
  • [10] Sulfonylurea treatment outweighs insulin therapy in short-term metabolic control of patients with permanent neonatal diabetes mellitus due to activating mutations of the KCNJ11 (KIR6.2) gene
    G. Tonini
    C. Bizzarri
    R. Bonfanti
    M. Vanelli
    F. Cerutti
    E. Faleschini
    F. Meschi
    F. Prisco
    E. Ciacco
    M. Cappa
    C. Torelli
    V. Cauvin
    S. Tumini
    D. Iafusco
    F. Barbetti
    Diabetologia, 2006, 49 : 2210 - 2213
12345